Comparative effects of some serum components and proteolytic products of fibrinogen on surface tension-lowering abilities of beractant and a synthetic peptide containing surfactant KL4.
about
Protein-containing synthetic surfactant versus protein-free synthetic surfactant for the prevention and treatment of respiratory distress syndromeProtein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndromeProtein containing synthetic surfactant versus animal derived surfactant extract for the prevention and treatment of respiratory distress syndromeLucinactant: a novel synthetic surfactant for the treatment of respiratory distress syndrome.The pulmonary physician in critical care - part 9: non-ventilatory strategies in ARDS.Function and inhibition sensitivity of the N-terminal segment of surfactant protein B (SP-B1-25) in preterm rabbits.A pharmacoeconomic analysis of in-hospital costs resulting from reintubation in preterm infants treated with lucinactant, beractant, or poractant alfa.Surfactant respiratory therapy using Surfaxin/sinapultide.An overview of pulmonary surfactant in the neonate: genetics, metabolism, and the role of surfactant in health and disease.Lucinactant attenuates pulmonary inflammatory response, preserves lung structure, and improves physiologic outcomes in a preterm lamb model of RDSLucinactant for the prevention of respiratory distress syndrome in premature infants.Evolution of surfactant therapy for respiratory distress syndrome: past, present, and future.Lucinactant: new and approved, but is it an improvement?Radiation Mitigating Properties of Intranasally Administered KL4 Surfactant in a Murine Model of Radiation-Induced Lung Damage.Lung volumes and alveolar expansion pattern in immature rabbits treated with serum-diluted surfactant.
P2860
Q24240106-ACC15EA1-A70B-44F9-BD90-EC01FFDA0658Q24243198-57BEDA42-72E3-4A34-B5FB-46F4EACF82A8Q24244224-D6DD6F7A-3BA3-4B67-87DF-086CF6C3C0D6Q34411762-D30A941A-2540-4F37-8063-22B16709C4D3Q34802362-E16AA38E-DA94-4634-8B50-F3C79B22BF58Q35534252-ED25580F-C106-4022-A536-4B03E5BF571DQ36479611-AA0BB857-37A2-4E99-968A-820EB73D82E1Q37362645-D20CD854-3FEA-4845-867F-CFAF67087901Q37418480-B53CF18F-7973-42B4-B7CC-D0FC82E936D4Q37466166-BC821647-68C5-4BE6-BDE3-E32EDE762512Q38087693-75D537C6-2E06-4D39-AF94-91DEDC3DC814Q38814650-15F565CA-AF20-4BB4-85CE-4F9DD8D21A75Q42422372-36301E81-0DDA-4D9A-BF54-280BBCFE22BAQ47781707-5CF5E46B-A87C-4877-B2A6-5E7B0657271EQ47929119-BE998BCF-E778-487D-9411-97A19DCE01F1
P2860
Comparative effects of some serum components and proteolytic products of fibrinogen on surface tension-lowering abilities of beractant and a synthetic peptide containing surfactant KL4.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年学术文章
@wuu
1996年学术文章
@zh-cn
1996年学术文章
@zh-hans
1996年学术文章
@zh-my
1996年学术文章
@zh-sg
1996年學術文章
@yue
1996年學術文章
@zh
1996年學術文章
@zh-hant
name
Comparative effects of some se ...... ide containing surfactant KL4.
@en
Comparative effects of some se ...... ide containing surfactant KL4.
@nl
type
label
Comparative effects of some se ...... ide containing surfactant KL4.
@en
Comparative effects of some se ...... ide containing surfactant KL4.
@nl
prefLabel
Comparative effects of some se ...... ide containing surfactant KL4.
@en
Comparative effects of some se ...... ide containing surfactant KL4.
@nl
P2093
P2860
P1433
P1476
Comparative effects of some se ...... ide containing surfactant KL4.
@en
P2093
C Cochrane
J Amirkhanian
T A Merritt
P2860
P304
P356
10.1203/00006450-199606000-00004
P407
P577
1996-06-01T00:00:00Z
P6179
1064208424